CMS released draft 2027 Star Ratings cutpoints to Medicare Advantage plans in September 2026. Reporting indicates that roughly half of the thresholds became more difficult to reach. Official results are expected in October.
This is more useful read as a vendor signal than as a payer story.
A plan comfortably at four stars under last year’s math may not be under this year’s. The four star threshold is what unlocks quality bonus payments and drives larger rebates for plans bidding below the CMS benchmark. A plan that slips below it does not have a quality problem in the abstract. It has a revenue problem with a specific number attached, discovered during the same weeks it is finalizing next year’s budget.
This compounds a change finalized in April 2026, when CMS eliminated eleven administrative process measures and shifted weight toward clinical outcomes and patient experience. Vendors who helped plans optimize the retired administrative metrics became less valuable. Vendors who can demonstrably move clinical quality and patient experience became more valuable. Same product, same plan, a different price.
The practical consequence is that the next several weeks are unusually good timing for one specific conversation. A company that can demonstrate movement on a named clinical or patient experience measure is calling on plans who have just learned they are short, and who have a quantified reason to take the meeting.
Generic quality language will not earn that meeting. The measure name will.